Sanofi has reached an agreement in principle to settle 4,000 US lawsuits linking the discontinued heartburn drug Zantac to cancer, the company said on Wednesday.
Sanofi did not disclose the financial terms of the deal. The agreement, which still needs to be finalized, will resolve most of the lawsuits against the French pharmaceutical company in US state courts, with the exception of Delaware where the majority of the cases are pending.
Sanofi did not admit any liability in the settlement, and said it is settling to avoid the expense and ongoing distraction of the litigation.
“Sanofi has vigorously defended the Zantac litigation since the outset and will continue to do so,” the company said in a statement.
Sanofi still faces about 20,000 lawsuits over Zantac in
→ Continue reading at CNN - Business News